Quest Diagnostics Aktie
WKN: 904533 / ISIN: US74834L1008
02.02.2023 13:06:26
|
Quest Diagnostics Guides FY23 Adj. EPS In Line With Estimates - Update
(RTTNews) - While reporting financial results for the fourth quarter on Thursday, Quest Diagnostics Inc. (DGX) initiated its earnings, adjusted earnings and revenue guidance for the full-year 2023.
For fiscal 2023, the company now projects earnings in a range of $7.61 and $8.21 per share and adjusted earnings in a range of $8.40 and $9.00 per share on net revenues between $8.83 billion and $9.03 billion.
On average, 16 analysts polled by Thomson Reuters expect the company to report earnings of $8.69 per share on revenues of $9.13 billion for the year. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Quest Diagnostics Inc.mehr Nachrichten
Analysen zu Quest Diagnostics Inc.mehr Analysen
Aktien in diesem Artikel
Quest Diagnostics Inc. | 144,40 | -1,53% |
|